Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, November 11 at 2:00 PM ET

Register Free →

R--U.S. Food and Drug Administration (FDA) submission and clearance of the Arsenal Medical, Inc. Wound Stasis System (WSS) medical device.

Active
W81XWH15WSSCMSFederal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The contract involves the United States Army Medical Research Acquisition Activity issuing a firm fixed-price, sole source agreement to Arsenal Medical Incorporated to support the FDA submission and clearance of the Arsenal Medical Wound Stasis System (WSS) medical device. This contract, guided by the FAR 6.302-1 sole source authority, aims to leverage the contractor's unique expertise and ongoing collaboration to ensure the device achieves regulatory approval. The effort includes providing subject matter expertise for the pivotal clinical trial, developing clinical protocols, producing test articles compliant with Quality System Regulations, and creating training materials for device users. The WSS is designed to treat intracavitary, noncompressible hemorrhage, a critical need in both military and civilian medical settings. The acquisition, classified under NAICS code 541711 with a size standard of 500 employees, reflects the government’s intent to maintain continuous development of this life-saving technology without competition due to the contractor’s specialized capabilities. While the notice solicits information on the capability of other potential contractors to meet the requirements, it is not a request for proposals. The ultimate goal is to minimize injury and fatality among service members through effective point-of-injury therapies, with the FDA clearance enabling broader availability of the WSS device. This contract underscores the importance of ongoing support to fulfill essential government medical mission needs.

General Info

Firm fixed-price sole source contract to Arsenal Medical for FDA clearance of Wound Stasis System.

Agency

N/A

NAICS

541711 - Research and Development in Biotechnology

Place of Performance

Not specified

Set-Aside

NONE

Documents

0

No documents available

Documents will appear here when they are available.

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

Posted

special-notice

Ready to pursue this opportunity?

Get full access to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyN/A
ContactsNo contacts available
OfficeN/A
Organization / Agency
N/A
Office AddressN/A
ContactsNo contact information available

Full Description

Show more
The United States Army Medical Research Acquisition Activity (USAMRAA) intends to issue a Firm Fixed-Price sole source contract under the authority of FAR 6.302-1 (a) (2) (ii) - Only One Responsible Source and No Other Services will Satisfy Agency Requirements, on or about 07 August 2015 to the Arsenal Medical Incorporated, 480 Arsenal Street, Watertown, MA 02472 on behalf of the United States Army Medical Materiel Agency (USAMMA). The North American Industrial Classification System (NAICS) code for this acquisition is 541711 and the size standard is 500 employees. The purpose of this effort is to obtain the U.S. Food and Drug Administration (FDA) submission and clearance of the Arsenal Medical, Inc. Wound Stasis System (WSS) medical device. The Contractor shall provide Subject Matter Expertise (SME) in the execution of the pivotal trial and applications training to support the Arsenal Medical, Inc. WSS medical device product development. This includes the development of the clinical protocols, Quality System Regulation (QSR) - compliant representative test articles for the study, and training material for users on the Arsenal Medical, Inc. WSS medical device. This is a new contract for support services based on the continual collaboration to advance the Arsenal Medical, Inc. WSS device through FDA approval for a treatment for intracavitary, noncompressible hemorrhage. The intent of the effort is to fulfill the current capability to effectively minimize, mitigate, and prevent injury and personal impact to the service member utilizing the Arsenal Medical, Inc. WSS medical device with point-of-injury therapies. By obtaining FDA approval for the Arsenal Medical, Inc. WSS medical device, the device can be made available to the military and civilian population to help save lives and prevent deaths. On-going support and development is essential to the Government's mission and needs, thereby precluding consideration of another entity. Interested contractors may identify their interest and bona fide capability to fulfill the requirement. This notice of intent is not a request for competitive proposals. Interested parties who believe they can meet this requirement shall submit information about their capabilities no later than 4:00 PM EST, 15 May 2015. All information shall be furnished at no cost or obligation to the Government. No solicitation will be made available. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement. A determination by the Government not to compete this proposed solicitation based upon responses to this notice is solely within the discretion of the Government. Telephone inquiries will not be accepted.

Similar Contracts

Same NAICS industry code

Earlier notices in this NAICS code

Posted before this notice, open and closed

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS